- This event has passed.
Sarah Kennedy and Dr. Edward Walker: Calocurb
April 2 @ 8:00 pm - 10:00 pm UTC-4
Introducing Calocurb the World’s First Oral GLP-1 Agonist with Sarah Kennedy and Dr. Edward Walker (from New Zealand, No Less!) the Founders and Inventors of Calocurb!
Amarasate®, the key ingredient is a specialized extract derived from New Zealand grown hops. (It’s beer?) Amarasate® extract was primarily developed to tackle issues of hunger, and food cravings.
Amarasate reduces caloric intake on average 18%, hunger 30% and food cravings 40%. It is released into the duodenum, from a delayed-release, patented capsule.
Amarasate stimulates the bitter taste-sensing type 2 receptors (TAS2Rs) on enteroendocrine cells to release gastric hormones (GLP-1 and CCK) at six times baseline levels, twice the normal post-prandial release. These gastric hormones signal a part of the brain to decrease appetite and food cravings plus slow down the gastric emptying rate.
Amarasate suppresses appetite without stimulant or caffeine. There is no bloating or GI upset. Each capsule contains only 3 ingredients: 125 mg of natural New Zealand Amarasate hops extract, rosemary extract, and vegetable oil.
- Reduce caloric intake by an average of 18%
- Reduce overall hunger by 30%
- Reduce overall food cravings by 40%
